Federated Hermes’s Qiagen QGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,450
Closed -$110K 2147
2025
Q4
$110K Sell
2,450
-110
-4% -$5.09K ﹤0.01% 1569
2025
Q3
$114K Sell
2,560
-155
-6% -$7.42K ﹤0.01% 1568
2025
Q2
$130K Sell
2,715
-1,024
-27% -$44.5K ﹤0.01% 1553
2025
Q1
$150K Buy
+3,739
New +$157K ﹤0.01% 1536
2024
Q2
Sell
-1
Closed -$43 2116
2024
Q1
$43 Buy
+1
New +$46 ﹤0.01% 2001
2023
Q4
Sell
-1,071
Closed -$46K 2176
2023
Q3
$46K Sell
1,071
-12,160
-92% -$567K ﹤0.01% 1679
2023
Q2
$632K Buy
13,231
+2,747
+26% +$132K ﹤0.01% 1289
2023
Q1
$511K Sell
10,484
-2,375
-18% -$121K ﹤0.01% 1394
2022
Q4
$680K Buy
12,859
+6,922
+117% +$341K ﹤0.01% 1257
2022
Q3
$260K Sell
5,937
-573
-9% -$28.3K ﹤0.01% 1479
2022
Q2
$326K Buy
+6,510
New +$318K ﹤0.01% 1449

Other funds holding QGEN

Federated Hermes's QGEN Position: Q1 2026 in Review

Federated Hermes sold out of Qiagen (QGEN) in Q1 2026, closing a stake of 2,450 shares — an estimated $110K sold.

Federated Hermes first reported a position in QGEN in Q2 2022 and held it in 11 quarters. The position peaked at $680K in Q4 2022. 343 funds tracked by Wall St. Rank hold QGEN as of Q1 2026.

  • Federated Hermes reported no remaining Qiagen position as of Q1 2026 after selling out during the quarter.
  • Federated Hermes sold 2,450 Qiagen shares in Q1 2026, an estimated $110K.
  • Federated Hermes first reported a position in Qiagen in Q2 2022 and held it in 11 quarters.
  • Federated Hermes's Qiagen position peaked at $680K in Q4 2022.
  • 343 funds tracked by Wall St. Rank held Qiagen as of Q1 2026.

Based on Federated Hermes's 13F filing for Q1 2026, filed 11 May 2026.